341
Participants
Start Date
December 14, 2022
Primary Completion Date
September 6, 2024
Study Completion Date
September 6, 2024
Ketorolac Tromethamine
Ketorolac tromethamine, alcohol free formulation, 1.0 mg/mL in saline solution (\~0.9% NaCl) adjusted to a pH of \~7.4. Contained in a sterile, 200 mL polyolefin bag (filled with 125 mL of NTM-001).
Morphine Sulfate
Morphine single use vials at 4 mg/mL, filled with 1 mL.
Intravenous Placebo for NTM-001
Placebo alcohol free saline solution (\~0.9% NaCl; matching active NTM-001). Contained in a sterile, 200 mL polyolefin bag (filled with 125 mL Placebo solution).
IV Placebo for Morphine
Placebo single use vials with saline (matching active morphine).
Chesapeake Research, Pasadena
Midwest Clinical Research Center, Dayton
Dr. Vince Clinical Research, Overland Park
The Orthopedic Center, Tulsa
Endeavor Clinical Trials, San Antonio
Sun City Clinical Research, Sun City
Alliance Research Intitute, Canoga Park
Pasadena Clinical Trials, Pomona
Trovare Clinical Research, Bakersfield
Curalta Clinical Trials, Westwood
Lead Sponsor
NEMA Research, Inc.
INDUSTRY